Antifungal activity of fluconazole in vitro
Pawlik, B.; Macura, A.B.
Medycyna Doswiadczalna i Mikrobiologia 47(1-2): 101-106
1995
ISSN/ISBN: 0025-8601 PMID: 8523965 Document Number: 452834
The susceptibility of 97 fungal strains to fluconazole was evaluated using the dilution method. Forty-three of the strains were C. albicans, fifty-three other Candida species and one S. cerevisiae. The MIC values varied from 0.1 mg/l to 100 mg/l. However, the growth of 75.2% of the strains was considerably inhibited at 0.1 mg/l. Forty-nine strains were tested using both the dilution and disk-diffusion methods. The findings were consistent. The latter method may be performed on YNB medium and is of practical value.
Document emailed within 1 workday
Related Documents
Uchida, K.; Hosaka, J.; Aoki, K.; Yamaguchi, H. 1991: In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with dermatomycoses Japanese Journal of Antibiotics 44(5): 571-579Desvignes, A.; Leluan, G.; Dupeyron, C. 1979: Determination of antifungal activity in vitro, against a strain of dermatophyte. II. Fungicidal activity Annales Pharmaceutiques Francaises 37(3-4): 139-142
Arzeni, D.; Barchiesi, F.; Ancarani, F.; Scalise, G. 1991: Fluconazole, itraconazole and ketoconazole in-vitro activity. A comparative study Journal of ChemoTherapy 3(3): 139-142
Pemán, J.; Cantón, E.; Orero, A.; Ubeda, P.; Viudes, A.; Pastor, A.; Gobernado, M. 1998: In vitro activity of fluconazole against Candida albicans isolated from blood culture Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 11(4): 339-343
Niwano, Y.; Matsui, M.; Tabuchi, T.; Kanai, K.; Hamaguchi, H.; Miyazaki, T.; Uchida, K.; Yamaguchi, H. 1997: Studies on the antifungal activity of the new imidazole antimycotic lanoconazole in infected sites. Distribution in the skin and in vitro activity in the presence of stratum corneum Arzneimittel-Forschung 47(9): 1056-1060
Pizzo, G.; Giuliana, G. 1998: Antifungal activity of chlorhexidine containing mouthrinses. An in vitro study Minerva Stomatologica 47(12): 665-671
Serrano-Martino, Mía.del.Carmen.; Chávez-Caballero, Mónica.; Valverde-Conde, A.; Claro, R.María.; Pemán, J.; Martín-Mazuelos, E. 2003: In vitro activity of voriconazole and three other antifungal agents against dermatophytes Enfermedades Infecciosas Y Microbiologia Clinica 21(9): 484-487
Cancet, B.; Amgar, A. 1987: In vitro antifungal activity of nitroxoline. Preliminary clinical results Pathologie-Biologie 35(5 Part 2): 879-881
Allegrini, J.; de Buochberg, M.S.; Pellecuer, J. 1974: In vitro study of the antibacterial and antifungal activity of essence of Satureia montana L. (labiees) Journal de Pharmacie de Belgique 29(2): 137-144
Millet-Clerc, J.; Michel, D.; Chaumont, J.P. 1989: Antifungal effects in vitro of jasmon and some similar compounds. Structure-activity relationship Annales Pharmaceutiques Francaises 47(3): 157-161
Bakht, J.; Naqash, G.; Shafi, M. 2014: Report: In vitro antibacterial and antifungal activity of different solvent extracted samples of Alhagi maurorum Pakistan journal of pharmaceutical sciences 27(6): 1953-1959
Maqsood, I.; Masood, M.I.; Nawaz, H.A.; Shahzadi, I.; Arslan, N. 2019: Formulation, characterization and in vitro evaluation of antifungal activity of Nystatin micro emulsion for topical application Pakistan Journal of Pharmaceutical Sciences 32(4): 1671-1677
Zaremba, M.; Borowski, J.; Feliński, J.; Rozkiewicz, D.; Rozkiewicz, M.; Zaremba, K.; Czerwiński, A.; Borowski, E. 1989: N, N, N-trimethylamphotericin B methyl ester chloride (DMS-AME): in vitro and in vivo antifungal activity studies in comparison with fungizone Journal of ChemoTherapy 1(4 Suppl): 243-245
Corelli, F.; Massa, S.; Stefancich, G.; Mai, A.; Artico, M.; Panico, S.; Simonetti, N. 1987: Antibacterial and antifungal compounds. VIII. Synthesis and antifungal activity of pyrrol derivatives similar to trichostatin a Il Farmaco; Edizione Scientifica 42(12): 893-903
Gautam, P.; Light, B.; Purvis, T. 2017: Stability of two Antifungal Agents, Fluconazole and Miconazole, Compounded in HUMCO RECURA Topical Cream to Determine Beyond-Use Date International Journal of Pharmaceutical Compounding 21(2): 154-159
Wildfeuer, A.; Laufen, H.; Haferkamp, O. 1990: Interaction of fluconazole and human phagocytic cells. Uptake of the antifungal agent and its effects on the survival of ingested fungi in phagocytes Arzneimittel-Forschung 40(9): 1044-1047
Urbanowski, S.; Nierebińska, E.; Gwieździński, Z. 1989: Antifungal activity of itraconazole and ketoconazole investigated in vitro, determined with minimal inhibitory concentrations and mycelial cell transformation in Candida albicans Przeglad Dermatologiczny 76(5-6): 405-409
Loriga, M.; Moro, P.; Sanna, P.; Paglietti, G.; Zanetti, S. 1997: Quinoxaline chemistry. Part 8. 2-[Anilino]-3-[carboxy]-6(7)-substituted quinoxalines as non classical antifolate agents. Synthesis and evaluation of in vitro anticancer, anti-HIV and antifungal activity Farmaco 52(8-9): 531-537
Khan, A.A.; Khurshid, M.; Tawfik, A.F. 2013: In vitro evaluation of vincristine and fluconazole combination against Candida Pakistan Journal of Pharmaceutical Sciences 26(5): 1037-1040
Fernández Andreu, C.M.; Martínez Machin, G.; Illnait Zaragozi, M.T.; Perurena Lancha, M.R.; Aguila Sánchez, A.; Galloso Brito, M. 2007: In vitro susceptibility of Candida strains to fluconazole and amphotericin B Revista Cubana de Medicina Tropical 59(2): 113-118